Genky DrugStores Co., Ltd. provided consolidated earnings guidance for the first half and full year of fiscal year ending June 20, 2023. For the first half of fiscal 2023, the company expects net sales of Ñ83,000 million, operating income of Ñ2,900 million and net income attributable to owners of parent of Ñ1,748 million and net Income per share of Ñ115.13.
For the year ending June 20, 2023, the company expects net sales of Ñ168,000 million, operating income of Ñ5,800 million and net income attributable to owners of parent of Ñ3,900 million net Income per share of Ñ256.87.